Affective vulnerability in substance use disorders. 2019

R Kathryn McHugh, and Elizabeth T Kneeland
Division of Alcohol and Drug Abuse, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: kmchugh@mclean.harvard.edu.

Substances of abuse are characterized by their rewarding effects and engagement of reward pathways in the brain. However, these substances also provide rapid relief of negative affect, and thus are highly negatively reinforcing. Accordingly, negative affectivity and other affective vulnerabilities (factors related to the experience of affect) are strongly linked to problematic substance use and substance use disorders. In this review, we provide a critical overview of the literature on affective vulnerabilities in substance use disorders. We discuss how both the experience of affect (e.g. negative affectivity, stress reactivity) and the interpretation of affect (e.g. distress intolerance, anxiety sensitivity) are pertinent to the development, maintenance, and treatment of substance use disorders.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000339 Affect The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves. Mood,Affects,Moods
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

R Kathryn McHugh, and Elizabeth T Kneeland
January 1984, American journal of psychoanalysis,
R Kathryn McHugh, and Elizabeth T Kneeland
June 2002, Neurotoxicity research,
R Kathryn McHugh, and Elizabeth T Kneeland
July 1997, The American journal of psychiatry,
R Kathryn McHugh, and Elizabeth T Kneeland
December 2004, The Psychiatric clinics of North America,
R Kathryn McHugh, and Elizabeth T Kneeland
January 2010, The Journal of neuropsychiatry and clinical neurosciences,
R Kathryn McHugh, and Elizabeth T Kneeland
April 2014, Trends in cognitive sciences,
R Kathryn McHugh, and Elizabeth T Kneeland
May 2021, Experimental neurology,
R Kathryn McHugh, and Elizabeth T Kneeland
February 2021, Neuropharmacology,
R Kathryn McHugh, and Elizabeth T Kneeland
February 2022, International review of psychiatry (Abingdon, England),
R Kathryn McHugh, and Elizabeth T Kneeland
January 1996, NIDA research monograph,
Copied contents to your clipboard!